Premium Only Content

Are New Alzheimer’s Drugs All They Promise To Be?
Researchers question the impact of amyloid immunotherapy on Alzheimer’s, highlighting the small benefits versus significant risks and costs.
Despite regulatory approval by the FDA, other bodies like the EMA express reservations, reflecting broader concerns about these treatments’ real-world efficacy.
Alzheimer’s Immunotherapy Challenges
Cambridge researchers have cast doubt on whether new amyloid immunotherapy drugs will have the desired effect of significantly reducing the impact of Alzheimer’s disease.
Writing in the journal Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, the team from Cambridge Public Health argues that substantial challenges including the risk-benefit ratio, limited eligibility, and high cost of the roll-out will limit any benefits of these treatments.
-
29:10
reallygraceful
19 hours ago $1.32 earnedWill GHISLAINE MAXWELL Be a Free Woman Soon?
16.9K57 -
4:25
Blackstone Griddles
16 hours agoBetty's Outback Chicken on the Blackstone Griddle
6.62K3 -
8:48
Hollywood Exposed
16 hours agoRob Schneider Just ENDED Stephen Colbert’s Career With ONE Brutal Truth
14.1K20 -
12:14
Nikko Ortiz
2 days agoMilitary Fails Of The Week
51.2K27 -
27:37
pewculture
7 days agoThe I, Robot Gun Looked Cool—Until We Found Out What It Really Was - EP#23 - I, Robot
17.6K10 -
56:00
Omar Elattar
9 months agoHow I Made $800M, Got Depressed & Now Spend $2M Per-Year On My Anti-Aging Health Routine!
25.6K2 -
24:24
GritsGG
16 hours agoSpectating Random Solos with the Rank 1 Player - Pro Strategies!
17.8K -
LIVE
Lofi Girl
2 years agoSynthwave Radio 🌌 - beats to chill/game to
489 watching -
9:27
MattMorseTV
2 days ago $17.85 earnedHe just lost EVERYTHING.
87.8K122 -
7:10:39
MyronGainesX
1 day agoFormer Fed Explains Serial Killer Israel Keyes, Yahweh ben Yaweh, And The El Rukn Gang, And Police Shooting Reactions!
149K38